Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CNTA |
---|---|---|
09:32 ET | 2029 | 8.5 |
09:36 ET | 500 | 8.5 |
09:41 ET | 840 | 8.53 |
09:45 ET | 528 | 8.465 |
09:50 ET | 378 | 8.53 |
10:01 ET | 484 | 8.46 |
10:17 ET | 200 | 8.51 |
10:30 ET | 321 | 8.485 |
10:32 ET | 1100 | 8.4995 |
10:33 ET | 100 | 8.5 |
10:42 ET | 641 | 8.53 |
10:57 ET | 604 | 8.59 |
11:00 ET | 807 | 8.61 |
11:02 ET | 105 | 8.61 |
11:58 ET | 300 | 8.63 |
12:03 ET | 300 | 8.6 |
12:09 ET | 340 | 8.63 |
12:25 ET | 869 | 8.6 |
12:32 ET | 12228 | 8.665 |
12:34 ET | 300 | 8.696 |
12:39 ET | 300 | 8.67 |
12:41 ET | 105 | 8.66 |
12:57 ET | 100 | 8.66 |
12:59 ET | 100 | 8.66 |
01:01 ET | 800 | 8.68 |
01:08 ET | 400 | 8.66 |
01:10 ET | 100 | 8.65 |
01:12 ET | 100 | 8.64 |
01:26 ET | 100 | 8.65 |
01:35 ET | 100 | 8.63 |
01:37 ET | 400 | 8.67 |
01:39 ET | 100 | 8.72 |
01:53 ET | 17000 | 8.676 |
02:00 ET | 200 | 8.64 |
02:04 ET | 1600 | 8.65 |
02:06 ET | 400 | 8.65 |
02:11 ET | 627 | 8.62 |
02:15 ET | 500 | 8.62 |
02:18 ET | 100 | 8.61 |
02:20 ET | 300 | 8.625 |
02:22 ET | 300 | 8.64 |
02:27 ET | 100 | 8.6275 |
02:29 ET | 400 | 8.645 |
02:31 ET | 1862 | 8.67 |
02:33 ET | 21939 | 8.67 |
02:36 ET | 698 | 8.68 |
02:40 ET | 200 | 8.67 |
02:45 ET | 700 | 8.67 |
02:47 ET | 100 | 8.67 |
02:49 ET | 200 | 8.685 |
02:51 ET | 6859 | 8.67 |
02:54 ET | 1949 | 8.615 |
02:56 ET | 2862 | 8.65 |
03:00 ET | 226 | 8.63 |
03:03 ET | 100 | 8.68 |
03:07 ET | 1300 | 8.655 |
03:09 ET | 200 | 8.7 |
03:20 ET | 16216 | 8.66 |
03:21 ET | 100 | 8.66 |
03:23 ET | 125 | 8.6999 |
03:32 ET | 900 | 8.68 |
03:38 ET | 600 | 8.65 |
03:41 ET | 100 | 8.64 |
03:48 ET | 344 | 8.67 |
03:50 ET | 500 | 8.68 |
03:52 ET | 220 | 8.68 |
03:56 ET | 600 | 8.7 |
03:57 ET | 200 | 8.695 |
03:59 ET | 4871 | 8.74 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Centessa Pharmaceuticals PLC | 969.9M | -6.2x | --- |
Cullinan Therapeutics Inc | 967.1M | -5.1x | --- |
Pharvaris NV | 916.9M | -6.5x | --- |
Autolus Therapeutics PLC | 928.5M | -2.9x | --- |
Enliven Therapeutics Inc | 1.0B | -11.6x | --- |
Tyra Biosciences Inc | 891.6M | -10.1x | --- |
Centessa Pharmaceuticals plc is a United Kingdom-based clinical-stage pharmaceutical company. Its advanced programs include a hemophilia program, an orexin agonist program for the treatment of narcolepsy and other sleep-wake disorders, and an immuno-oncology program focused on its LockBody technology platform. SerpinPC, its advanced product candidate, is an investigational, potentially first-in-class subcutaneously administered novel inhibitor of activated protein C for hemophilia. Its Orexin Receptor 2 (OX2R) Agonist Program includes ORX750, which is an investigational, orally administered, selective OX2R agonist designed to directly target the underlying pathophysiology of orexin neuron loss in narcolepsy type 1 and to address sleep-wake disorders with normal orexin levels such as narcolepsy type 2 and idiopathic hypersomnia. It is also exploring follow-up orexin agonists for potential expansion opportunities into a range of sleep-wake disorders and broader neurological indications.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $969.9M |
---|---|
Revenue (TTM) | $6.9M |
Shares Outstanding | 113.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.42 |
Book Value | $2.39 |
P/E Ratio | -6.2x |
Price/Sales (TTM) | 141.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,312.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.